hypersensitivity vasculitis: Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
179 |
4. Check minimum number of eventsNone |
179 |
5. Include endpointsNone |
179 |
6. Filter based on genotype QC (FinnGen only) |
179 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M31
- Name in latin
- Angi(i)tis hypersensitivitatis
Similar endpoints
↥List of similar endpoints to
Hypersensitivity angiitis
based on the number of shared cases.
Similar with more cases:
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1066 | 579 | 476 |
| Only index persons | 811 | 452 | 359 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 60.49 | 61.23 | 59.53 |
| Only index persons | 57.92 | 58.46 | 57.23 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 179 | 94 | 85 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 58.05 | 56.90 | 59.32 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 164
- Matched controls
- 1638
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
111.6
94
*
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
65.0
58
*
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
60.2
54
*
L04AX01
ATC
azathioprine; systemic
61.2
54.1
62
16
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
19.8
52.3
87
88
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
48.3
44
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
59.1
43.4
50
12
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
67.1
42.6
48
10
L04AA06
ATC
mycophenolic acid; systemic
96.1
40.2
43
6
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
36.9
34
*
H02AB04
ATC
methylprednisolone; systemic
10.3
31.8
71
113
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
17.5
31.4
51
41
A11CC03
ATC
alfacalcidol; systemic
32.6
30.6
40
16
4462A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Hypersensitivity angiitis
+∞
30.1
28
*
Z94.0
ICD-10 Finland
Kidney transplant status
98.2
30.0
32
*
TK800
NOMESCO Finland
Hemodialysis
30.3
27.1
36
15
A12AA04
ATC
calcium carbonate; oral
43.7
26.4
32
9
127
Kela drug reimbursment
Transplant complication
69.8
26.0
29
5
Z49.1
ICD-10 Finland
Extracorporeal dialysis
47.2
26.0
31
8
WW400
NOMESCO Finland
Plasmaferesis
292.6
25.4
25
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
66.9
24.9
28
5
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
139.5
23.2
24
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.5
23.2
97
339
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
45.7
22.5
27
7
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.4
22.5
44
51
L01AA01
ATC
cyclophosphamide; systemic
+∞
22.4
21
*
B03XA02
ATC
darbepoetin alfa; parenteral
40.0
21.9
27
8
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
15.6
20.5
34
27
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.9
19.3
38
44
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
41.9
18.1
22
6
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
17.0
16
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
100.4
16.9
18
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
12.8
16.8
30
28
N18.0
ICD-10 Finland
End-stage renal disease
45.1
16.8
20
5
KA1AE
NOMESCO Finland
Kidney ultrasound examination
19.8
16.2
24
14
N18.8
ICD-10 Finland
Other chronic renal failure
16.0
16.2
26
19
M05BA04
ATC
alendronic acid; oral
7.1
16.1
42
76
TPX10
NOMESCO Finland
Implantation of vascular injection port
17.1
16.0
25
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
16.0
101
469
C03CA01
ATC
furosemide; systemic
4.1
15.9
85
340
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
15.9
15
*
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
15.9
15
*
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
15.9
15
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
94.3
15.9
17
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
15.0
50
123
H02AB06
ATC
prednisolone; systemic
3.8
14.7
103
506
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
11.0
14.7
28
30
TPH04
NOMESCO Finland
Cathetrisation of vein
4.5
14.6
61
191
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.1
14.5
29
34
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.9
14.1
51
137
H02AB07
ATC
prednisone; oral
5.5
13.8
44
102
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
13.7
13
*
L04AD01
ATC
ciclosporin; systemic
28.6
13.7
18
7
WW200
NOMESCO Finland
Immunization
17.0
13.5
21
14
B03XA01
ATC
erythropoietin; parenteral
31.3
13.2
17
6
ZX120
NOMESCO Finland
Intravenous
6.0
13.1
38
78
A07AA02
ATC
nystatin; oral
7.2
13.0
32
53
137
Kela drug reimbursment
Uraemia requiring dialysis
75.9
12.8
14
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
75.9
12.8
14
*
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
12.7
12
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
12.7
12
*
WX892
NOMESCO Finland
Monitored bed care
6.8
12.5
32
56
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
40.9
12.4
15
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
23.5
12.3
17
8
R4110
NOMESCO Finland
Physiotherapy
3.7
12.1
66
254
ZX108
NOMESCO Finland
Inhalation
50.7
12.1
14
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
12.5
11.9
21
19
V03AE01
ATC
polystyrene sulfonate; oral
32.7
11.9
15
5
R50.9
ICD-10 Finland
Fever, unspecified
5.1
11.9
40
98
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.2
11.1
36
84
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
11.1
40
105
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
4.0
11.1
50
163
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
11.2
10.9
20
20
J01MA02
ATC
ciprofloxacin; systemic
3.1
10.8
87
437
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.8
10.7
27
46
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.4
10.6
28
51
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
10.5
10
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
8.9
10.5
22
28
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.1
10.3
19
19
L04AA01
ATC
[U] ciclosporin; systemic
28.0
10.0
13
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
9.9
64
272
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
105.8
9.5
10
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
9.5
9
*
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
+∞
9.5
9
*
J01MA14
ATC
moxifloxacin; systemic
5.3
9.4
29
64
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
25.7
9.0
12
5
TKC20
NOMESCO Finland
Catheterisation of bladder
5.8
8.9
25
49
R31
ICD-10 Finland
Unspecified haematuria
4.8
8.9
30
73
XF400
NOMESCO Finland
ECG with 12 standard connections
3.6
8.9
44
153
B05DA
ATC
Isotonic solutions
94.7
8.5
9
*
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
8.4
8
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
8.4
8
*
N19
ICD-10 Finland
Unspecified kidney failure
7.5
8.3
19
28
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.5
8.3
21
36
J01FF01
ATC
clindamycin; systemic
2.9
8.2
61
276
TK810
NOMESCO Finland
Hemofiltration
35.2
8.2
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.7
8.0
27
66
205
Kela drug reimbursment
Chronic hypertension
2.7
7.9
68
339
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.4
7.8
28
73
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.6
7.6
26
64
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.1
7.6
30
85
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
7.6
58
267
A02BC02
ATC
pantoprazole; systemic
2.6
7.6
115
775
B01AB10
ATC
tinzaparin; parenteral
5.2
7.6
23
50
GD1AD
NOMESCO Finland
Thorax CT examination
6.8
7.5
18
29
Z49.2
ICD-10 Finland
Other dialysis
83.7
7.5
8
*
321
Kela drug reimbursment
Paricalcitol and cinacalcet
83.7
7.5
8
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
83.7
7.5
8
*
D69.0
ICD-10 Finland
Allergic purpura
83.7
7.5
8
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
83.7
7.5
8
*
WX203
NOMESCO Finland
Infraclavicular plexus blockade
11.6
7.4
13
12
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
+∞
7.3
7
*
N085, M318
ICD-10 Finland
NA
+∞
7.3
7
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
7.3
7
*
N25.0
ICD-10 Finland
Renal osteodystrophy
+∞
7.3
7
*
C08CA02
ATC
felodipine; oral
3.8
7.3
31
94
ZXA00
NOMESCO Finland
Right side
2.7
7.2
61
298
Z49.0
ICD-10 Finland
Preparatory care for dialysis
21.1
7.2
10
5
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
9.4
7.2
14
16
R4190
NOMESCO Finland
Nutritional therapy
9.4
7.2
14
16
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.0
7.2
19
35
J01MA12
ATC
levofloxacin; systemic
3.0
7.2
44
177
P01BA02
ATC
hydroxychloroquine; oral
5.0
7.1
22
49
TGC00
NOMESCO Finland
Bronchial lavation
8.1
7.1
15
20
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
11.6
6.9
12
11
N17.8
ICD-10 Finland
Other acute renal failure
17.6
6.8
10
6
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
41.8
6.8
8
*
WX002
NOMESCO Finland
Sedation and analgesia
2.9
6.7
46
196
A41.9
ICD-10 Finland
Sepsis, unspecified
7.4
6.7
15
22
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
10.7
6.6
12
12
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.1
6.6
37
139
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.3
6.5
35
126
XQ845
NOMESCO Finland
Dermatoscopy
15.1
6.5
10
7
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
72.5
6.5
7
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
72.5
6.5
7
*
A02BC01
ATC
omeprazole; systemic
2.5
6.4
58
290
N02AX02
ATC
tramadol; systemic, rectal
2.4
6.4
79
462
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
6.4
31
105
L57.0
ICD-10 Finland
Actinic keratosis
3.7
6.4
27
82
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
6.8
6.3
15
24
C08CA01
ATC
amlodipine; oral
2.4
6.3
71
396
V03AE02
ATC
sevelamer; oral
27.8
6.3
8
*
6BA02
NOMESCO Finland
NA
+∞
6.3
6
*
1CX01
NOMESCO Finland
NA
+∞
6.3
6
*
PAW37
NOMESCO Finland
Biopsy of temporal artery
+∞
6.3
6
*
4476A
ICD-9 Finland
Other disorders of arteries and arterioles, Arteritis, unspecified
+∞
6.3
6
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
+∞
6.3
6
*
N085M
ICD-10 Finland
NA
+∞
6.3
6
*
B05DB
ATC
Hypertonic solutions
+∞
6.3
6
*
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
6.3
6
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.3
6.3
18
37
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
6.3
57
284
UKC02
NOMESCO Finland
Cystoscopy
3.1
6.1
34
126
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.1
6.1
23
63
TQW99
NOMESCO Finland
Other minor procedure on skin
5.8
6.0
16
30
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
34
20.58
60.42
5.8
1.1
16.2
—
iu/ml
—
11
0
51
44
15.81
52.21
4.2
1.4
91.4
—
titre
—
7
0
89
179
8.90
47.95
25.9
6.5
1.2
1.0
mmol/l
3.30
84
167
39
24
20.50
47.54
2.8
1.1
400.0
—
titre
—
10
0
37
8
57.80
32.05
8.6
1.1
42.6
—
u/ml
—
5
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
48
9.14
26.50
3.4
2.0
0.2
0.3
u/ml
0.73
20
28
26
22
13.66
26.20
1.4
1.2
—
—
—
0
0
70
194
5.28
24.92
8.7
2.6
21.9
21.1
%
0.24
61
169
25
22
13.05
24.55
1.6
1.2
344.1
275.2
u/ml
0.20
17
14
75
228
4.94
23.71
5.4
3.6
0.8
0.8
mmol/l
0.01
69
214
55
136
5.39
22.10
16.9
4.0
1.3
2.1
mmol/l
0.82
49
103
58
158
4.95
20.67
2.0
1.6
—
—
—
0
0
70
225
4.47
20.16
2.5
1.7
—
—
—
0
0
57
163
4.66
18.97
2.1
1.7
—
—
—
0
0
44
104
5.28
18.38
1.7
3.0
60.5
66.8
g/l
6.16
39
91
15
0
+∞
15.86
5.1
0.0
—
—
—
0
0
108
532
3.60
15.82
13.8
3.1
—
—
—
0
0
27
47
6.59
15.44
2.6
1.2
—
—
—
0
0
48
142
4.25
14.99
4.4
3.7
—
—
—
0
0
24
38
7.14
14.97
1.7
1.6
—
—
—
0
0
16
16
10.88
14.23
1.1
1.1
—
—
—
0
0
19
25
8.38
13.83
1.5
1.6
—
—
—
0
0
91
431
3.26
13.68
10.6
3.9
43.5
7.9
mg/mmol
1.33
76
265
22
37
6.64
12.93
1.5
1.5
—
—
—
0
0
32
78
4.78
12.67
7.6
5.8
24.3
25.1
mmol/l
0.54
32
78
132
811
3.39
12.17
20.3
8.8
4.4
4.2
e9/l
0.59
125
709
13
12
11.60
12.10
1.3
1.3
—
—
—
0
0
61
247
3.23
11.63
10.2
2.8
0.5
1.0
e6/l
1.90
45
148
37
108
4.06
11.59
1.8
1.4
—
—
—
0
0
120
711
3.09
11.52
34.7
7.6
1.2
1.2
mmol/l
0.02
106
594
14
16
9.41
11.27
1.7
1.4
—
—
—
0
0
117
689
3.02
11.26
9.3
3.7
0.0
0.0
estimate
0.00
20
117
12
11
11.62
11.18
4.2
4.4
—
—
—
0
0
115
677
2.95
10.96
9.3
3.7
0.0
0.0
estimate
0.00
20
127
115
679
2.94
10.87
13.8
5.0
0.0
0.0
estimate
0.00
21
119
19
34
6.13
10.47
5.9
1.2
—
—
—
0
0
57
235
3.09
10.41
10.8
2.9
1.6
2.2
e6/l
0.29
42
138
70
324
2.91
10.39
4.1
2.4
—
—
—
0
0
16
24
7.22
10.36
1.6
1.5
—
—
—
0
0
32
92
4.02
10.17
8.3
3.9
114.7
125.9
g/l
2.20
32
92
17
30
6.16
9.47
1.4
1.1
2.0
2.5
u/ml
—
5
5
17
31
5.95
9.16
1.5
1.6
—
—
—
0
0
11
12
9.70
9.07
2.0
1.3
—
—
—
0
0
23
57
4.48
8.83
1.6
1.6
—
—
—
0
0
16
29
5.96
8.66
1.7
1.4
—
—
—
0
0
16
29
5.96
8.66
1.7
1.4
—
—
—
0
0
15
26
6.21
8.48
1.4
1.6
—
—
—
0
0
11
5
23.29
8.12
1.0
1.0
—
—
—
0
0
10
13
8.09
7.19
1.2
1.8
—
—
—
0
0
16
35
4.92
7.08
1.8
1.3
—
—
—
0
0
10
14
7.51
6.77
1.2
1.7
—
—
—
0
0
19
50
4.13
6.73
1.7
2.8
—
—
—
0
0
13
25
5.53
6.59
1.2
1.6
—
—
—
0
0
23
71
3.57
6.54
2.7
1.4
—
—
—
0
0
53
267
2.40
6.18
1.8
1.7
1141.1
1179.4
nmol/l
0.11
47
205
91
580
2.16
5.97
7.9
2.6
181.4
127.9
ug/l
1.83
86
525
98
643
2.16
5.97
5.6
4.7
—
—
—
0
0
16
41
4.19
5.85
1.4
1.2
—
—
—
0
0
64
359
2.22
5.76
2.6
2.0
2.8
3.2
mg/l
1.16
55
311
119
855
2.17
5.58
10.8
5.0
6.6
6.7
mmol/l
0.35
113
789
51
265
2.29
5.48
4.2
3.8
657.6
132.3
ng/l
0.97
42
215
13
30
4.59
5.39
1.2
1.6
—
—
—
0
0
29
117
2.76
5.28
4.8
3.2
40.4
61.6
ml/min/173m2
—
8
49
38
176
2.47
5.26
9.1
9.9
-0.7
1.5
mmol/l
1.81
30
143
8
6
13.87
5.13
1.5
1.2
—
—
—
0
0
136
1050
2.23
5.03
10.6
3.7
19.1
12.6
mm/h
3.36
128
952
14
38
3.91
4.75
1.6
1.4
—
—
—
0
0
15
43
3.72
4.72
1.7
1.6
—
—
—
0
0
10
21
4.98
4.59
5.0
2.6
56.8
57.6
%
—
10
21
75
488
1.92
4.28
5.6
3.4
2.3
2.4
mmol/l
2.37
67
423
21
81
2.80
4.15
14.7
3.9
24.6
25.0
mmol/l
0.19
21
81
8
12
6.92
3.71
1.4
1.4
—
—
—
0
0
8
12
6.92
3.71
1.5
1.4
—
—
—
0
0
9
17
5.51
3.56
4.2
3.6
—
—
—
0
0
8
13
6.38
3.54
1.8
1.9
342.7
704.7
e6/l
—
8
6
10
27
3.86
3.40
1.4
1.3
—
—
—
0
0
9
19
4.93
3.28
1.3
1.2
—
1.4
u/ml
—
0
5
8
15
5.53
3.23
1.6
1.7
—
—
—
0
0
8
15
5.53
3.23
1.6
1.7
—
—
—
0
0
8
15
5.53
3.23
1.6
1.7
—
—
—
0
0
7
11
6.57
3.21
3.0
2.5
—
—
—
0
0
25
121
2.24
3.11
9.3
4.1
1.2
1.2
mmol/l
0.77
25
104
6
8
7.71
3.08
1.5
1.4
—
—
—
0
0
6
9
6.85
2.89
1.5
1.3
—
—
—
0
0
13
48
2.84
2.78
1.7
1.4
—
—
—
0
0
5
6
8.52
2.76
2.6
2.0
115.4
76.0
ug/l
—
5
6
75
543
1.66
2.71
10.8
3.9
—
—
—
0
0
63
436
1.69
2.70
3.3
2.9
4799.2
1249.2
ng/l
0.78
53
364
78
573
1.64
2.64
2.1
2.0
93.0
96.3
pmol/l
0.21
41
305
8
20
4.14
2.60
1.5
1.1
—
—
—
0
0
6
11
5.60
2.56
1.2
1.0
—
—
—
0
0
12
47
2.66
2.32
1.3
1.2
—
—
—
0
0
12
48
2.61
2.23
1.3
1.2
—
—
—
0
0
12
48
2.61
2.23
3.8
1.8
—
—
—
0
0
5
10
5.11
2.08
1.4
1.1
—
—
—
0
0
5
10
5.11
2.08
1.4
1.1
—
—
—
0
0
19
98
2.05
2.04
2.1
1.5
—
—
—
0
0
7
21
3.42
1.98
2.0
1.1
—
—
—
0
0
16
78
2.15
1.98
13.7
4.4
54.2
53.2
%
0.05
16
78
5
11
4.64
1.95
1.4
1.1
—
—
—
0
0
5
11
4.64
1.95
1.4
1.1
—
—
—
0
0
5
11
4.64
1.95
1.4
1.1
—
—
—
0
0
52
371
1.57
1.89
10.3
3.9
0.0
0.0
estimate
0.00
19
117
11
47
2.43
1.81
3.7
1.7
—
—
—
0
0
5
14
3.64
1.62
1.6
1.2
—
—
—
0
0
5
14
3.64
1.62
1.6
4.5
—
—
—
0
0
15
81
1.93
1.45
1.2
1.3
—
—
—
0
0
6
22
2.78
1.44
1.0
1.0
—
—
—
0
0
7
29
2.47
1.40
1.1
1.1
—
—
—
0
0
6
23
2.66
1.38
1.5
1.5
—
—
—
0
0
5
18
2.83
1.29
1.2
1.2
—
—
—
0
0
69
576
1.32
1.00
5.3
3.8
126.2
42.0
ng/l
0.72
57
407
150
1412
1.38
0.83
49.7
14.5
25.6
24.5
mg/l
0.18
143
1118
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
29
226
1.34
0.67
1.2
1.2
26.9
37.1
iu/ml
0.46
11
77
127
1350
0.80
0.66
4.9
4.7
5.9
6.0
mmol/l
0.17
118
1224
5
30
1.69
0.62
1.8
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
0
23
0.00
0.58
0.0
2.2
—
34.9
—
0
8
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
32
389
0.78
0.57
4.0
4.3
27.5
21.7
%
0.84
17
192
6
38
1.60
0.55
1.0
1.3
—
—
—
0
0
121
1283
0.82
0.54
5.6
4.6
2.0
1.9
mu/l
0.08
114
1142
22
171
1.33
0.53
2.3
4.7
3.9
68.0
ug/l
0.83
17
149
97
892
1.19
0.52
3.9
2.9
70.6
50.4
u/l
0.66
91
835
19
147
1.33
0.47
1.8
2.4
0.2
0.2
g/l
0.66
19
134
5
33
1.53
0.41
1.0
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
7.3
—
0
9
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
5
35
1.44
0.39
1.4
1.3
—
—
—
0
0
132
1264
1.17
0.37
53.1
15.4
35.2
39.8
%
5.16
93
897
21
178
1.20
0.27
1.6
1.4
—
—
—
0
0
136
1398
0.89
0.24
6.4
5.1
2.7
2.7
mmol/l
0.06
131
1277
127
1309
0.90
0.23
5.6
4.1
1.4
1.3
mmol/l
1.05
120
1187
132
1282
1.11
0.22
7.7
6.1
37.4
40.2
mmol/mol
4.44
127
1186
0
10
0.00
0.21
0.0
1.7
—
25.4
—
0
10
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
12
144
0.82
0.20
1.4
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
28
254
1.12
0.17
1.5
1.5
—
—
—
0
0
88
846
1.08
0.16
3.4
2.8
—
—
—
0
0
6
75
0.79
0.16
1.3
1.0
—
—
—
0
0
133
1358
0.92
0.15
6.2
4.5
1.5
1.5
mmol/l
0.39
128
1241
107
1040
1.07
0.14
4.9
3.8
14.8
14.8
pmol/l
0.07
99
922
134
1365
0.93
0.13
6.2
4.5
4.6
4.6
mmol/l
0.07
128
1254
130
1322
0.94
0.10
41.5
13.8
60.7
79.6
ml/min/173m2
7.19
117
1065
12
132
0.90
0.07
1.3
2.2
—
—
—
0
0
33
321
1.03
0.02
1.3
1.2
1.0
0.9
u/ml
—
6
76
18
185
0.97
0.00
18.5
8.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
1.2
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.0
—
14.1
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint M13_HYPERANG and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_HYPERANG | 3.134 [2.31, 4.24] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.178 |
During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 383 females with M13_HYPERANG died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_HYPERANG | 2.479 [1.81, 3.4] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.032 |
During the follow-up period (1.1.1998 — 31.12.2019), 118 out of 304 males with M13_HYPERANG died.
Mortality risk
Mortality risk for people of age
years, who have M13_HYPERANG.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.298% | 0.555% |
| 5 | 1.629% | 3.059% |
| 10 | 4.34% | 7.777% |
| 15 | 7.969% | 14.342% |
| 20 | 13.634% | 23.512% |
Relationships between endpoints
↥Index endpoint: M13_HYPERANG – Hypersensitivity angiitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data